USP44 and colorectal cancer: In recent years, studies have shown that the expression of USP44 in a variety of tumors has been significantly reduced, including colorectal cancer, breast cancer, esophageal cancer, glioblastoma, renal cancer and testicular cancer (Zhang et al., 2012).